Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1

Conditions

Signs and Symptoms 1Sexuality 1Sexual Dysfunction, Physiological 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 87fludarabine 74Tacrolimus 45fludarabine phosphate 44Mycophenolic Acid 42Whole-Body Irradiation 41Busulfan 35Melphalan 31Antilymphocyte Serum 24thymoglobulin 22Methotrexate 22Rituximab 21Standard of Care 20Sirolimus 20Azacitidine 20venetoclax 19Thiotepa 19Stem Cell Transplantation 18Granulocyte Colony-Stimulating Factor 18Practice Guidelines as Topic 16Cytarabine 16Nivolumab 15Filgrastim 15Dexamethasone 14Cyclosporine 13Bortezomib 13Mesna 12Peripheral Blood Stem Cell Transplantation 11trametinib 10Specimen Handling 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hematologic Neoplasms × Sexual Health × Clear all
NCT05222282 2023-09-28

Sexual Health in Patients With Hematologic Malignancies

Rigshospitalet, Denmark

Phase NA Unknown
110 enrolled
OtherOther hematologic neoplasm

Sexual Dysfunction, Physiological, Signs and Symptoms, Hematologic Neoplasms, Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon âš¡